Company intelligence / Profile preview

Dr. Diary

Seoul, Seoul Special City, South Koreadoctordiary.bma.org.uk ↗

Ownership: Private
Development stage: Commercial

Overview

Dr. Diary has developed a leading mobile application in South Korea for diabetes self-management, education, and coaching based on behavioral change models. The company has expanded into wellness foods tailored for diabetic patients, achieving over 30% annual revenue growth with significant domestic sales exceeding KRW 10 billion in 2023.

Therapeutic areas: Endocrinology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Samsung HealthSamchullySamsung Life InsuranceTop Internal Medicine Health Screening CenterSeoul Seocho District Office

Beyond the preview

Go deeper on Dr. Diary.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dr. Diary.

Explore the full profile